{"id":44398,"date":"2022-05-26T20:01:37","date_gmt":"2022-05-26T18:01:37","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/"},"modified":"2022-05-26T20:01:37","modified_gmt":"2022-05-26T18:01:37","slug":"vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/","title":{"rendered":"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting"},"content":{"rendered":"<div>\n<p>AMSTERDAM&#8211;(BUSINESS WIRE)&#8211;VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, today announces presentation of a poster at the European Network to Cure ALS (ENCALS) Annual Meeting at the University of Edinburgh on 1-3 June, 2022.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/4\/VectorY_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg\"><\/a><\/p>\n<p>\nMembers of the VectorY team will attend the conference in person and will be available to discuss the poster.\n<\/p>\n<p>\nThe details of the poster can be found below:\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<i>VecTabs: Selective targeting of protein aggregates and oxidized phospholipids for the treatment of Amyotrophic Lateral Sclerosis \u2013 Marina Sogorb-Gonzalez, et al. Wednesday 1 June 2022, McEwan Hall, d114<\/i>\n<\/li>\n<\/ul>\n<p>\nTo meet the team, please contact <a target=\"_blank\" href=\"&#109;&#x61;i&#108;&#x74;o&#58;&#x69;n&#102;&#x6f;&#64;&#118;&#x65;c&#116;&#x6f;r&#121;&#x74;x&#46;&#x63;o&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#105;n&#x66;o&#x40;v&#x65;c&#x74;&#111;&#x72;&#121;&#x74;&#120;&#x2e;&#99;o&#109;<\/a>.\n<\/p>\n<p class=\"bwalignc\">\n<b>ENDS<\/b>\n<\/p>\n<p>\n<b>Notes to Editors<\/b>\n<\/p>\n<p>\n<b>About VectorY<br \/>\n<br \/><\/b>VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions for neurodegenerative and -muscular diseases with high unmet medical need. Founded in October 2020 and based in the Amsterdam Science Park, VectorY is a fully integrated gene therapy company focused on the development of innovative therapeutics based on a novel AAV gene therapy platform, antibody-based targeted protein degradation technologies and proprietary manufacturing technology. While focusing initially on neurodegenerative and -muscular diseases, VectorY&#8217;s synergistic technologies may be applied across a wide range of indications. VectorY\u2019s manufacturing capabilities will include a state-of-the-art multi-product GMP facility in the Netherlands.\n<\/p>\n<p>\nFor more information, see <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.vectorytx.com&amp;esheet=52732193&amp;newsitemid=20220526005669&amp;lan=en-US&amp;anchor=www.vectorytx.com&amp;index=1&amp;md5=455b1bb65e1a187fbd68b1b92c656dd8\" rel=\"nofollow noopener\" shape=\"rect\">www.vectorytx.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nFor further information, please contact:\n<\/p>\n<p>\n<b>VectorY B.V.<\/b><br \/>Alexander Vos, CEO<br \/>\n<br \/>Tel: ++31 (20) 226 8020<br \/>\n<br \/><b>Instinctif Partners (media enquiries)<\/b><br \/>Melanie Toyne-Sewell \/ Katie Duffell<br \/>\n<br \/>E-mail: <a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;&#x74;&#111;:&#x56;&#101;&#x63;&#116;o&#x72;&#89;&#x40;&#105;n&#x73;t&#x69;&#110;&#x63;&#x74;i&#x66;&#46;&#x63;&#111;m\" rel=\"nofollow noopener\" shape=\"rect\">&#x56;&#101;c&#x74;&#x6f;&#114;Y&#x40;&#105;n&#x73;&#x74;&#105;n&#x63;&#116;i&#x66;&#x2e;&#99;o&#x6d;<\/a><br \/>Tel: +44 20 7457 2020\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>AMSTERDAM&#8211;(BUSINESS WIRE)&#8211;VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, today announces presentation of a poster at the European Network to Cure ALS (ENCALS) Annual Meeting at the University of Edinburgh on 1-3 June, 2022. Members of the VectorY &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44398","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"AMSTERDAM&#8211;(BUSINESS WIRE)&#8211;VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, today announces presentation of a poster at the European Network to Cure ALS (ENCALS) Annual Meeting at the University of Edinburgh on 1-3 June, 2022. Members of the VectorY ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-26T18:01:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting\",\"datePublished\":\"2022-05-26T18:01:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/\"},\"wordCount\":270,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005669\\\/en\\\/1468763\\\/21\\\/VectorY_logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/\",\"name\":\"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005669\\\/en\\\/1468763\\\/21\\\/VectorY_logo.jpg\",\"datePublished\":\"2022-05-26T18:01:37+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005669\\\/en\\\/1468763\\\/21\\\/VectorY_logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220526005669\\\/en\\\/1468763\\\/21\\\/VectorY_logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/","og_locale":"en_US","og_type":"article","og_title":"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting - Pharma Trend","og_description":"AMSTERDAM&#8211;(BUSINESS WIRE)&#8211;VectorY Therapeutics, a biotech company focusing on the development of innovative gene therapy approaches for the treatment of muscular and neurodegenerative disorders through vectorized antibodies, today announces presentation of a poster at the European Network to Cure ALS (ENCALS) Annual Meeting at the University of Edinburgh on 1-3 June, 2022. Members of the VectorY ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-26T18:01:37+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting","datePublished":"2022-05-26T18:01:37+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/"},"wordCount":270,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/","url":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/","name":"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg","datePublished":"2022-05-26T18:01:37+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220526005669\/en\/1468763\/21\/VectorY_logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/vectory-to-present-a-poster-at-the-european-network-to-cure-als-encals-annual-meeting\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"VectorY to Present a Poster at the European Network to Cure ALS (ENCALS) Annual Meeting"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44398","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44398"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44398\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44398"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44398"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44398"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}